ESC 365 - The administration of valproic acid exerts a protective effect by reducing the infarct size and the triggering of ventricular fibrillation in an experimental model of chronic myocardial infarction

ESC Professional Premium Access

The administration of valproic acid exerts a protective effect by reducing the infarct size and the triggering of ventricular fibrillation in an experimental model of chronic myocardial infarction

Session: Targeting remodeling of the injured heart

Topic: Ischaemia, Infarction, Cardioprotection

Speaker: Miss P. Genoves (Valencia, ES)

Event: ESC Congress 2022

Congress Presentation

Add to my library

About the speaker

Miss Patricia Genoves

University of Valencia, Valencia (Spain)

0 follower

4 more presentations in this session

The regenerative response of cardiac interstitial cells

Speaker: Doctor C. Jopling (Montpellier, FR)

Deficiency of pituitary adenylate cyclase-activating peptide and its receptor PAC1 confers interstitial cardiac fibrosis in a murine model of metabolic stress

Speaker: Mr J. Schubart (Kassel, DE)

Cardiac sympathetic afferent denervation reduces matrix metalloproteinase expression and improves cardiac remodeling in rats post myocardial infarction

Speaker: Professor I. Zucker (Omaha, US)

Human epididymis protein 4 indicates progression of cardiac fibrosis in Heart Failure with preserved Ejection Fraction.

Speaker: Doctor N. Nakashima (Kumamoto, JP)

Access the full session

Targeting remodeling of the injured heart

Speakers: Miss P. Genoves, Doctor C. Jopling, Mr J. Schubart, Professor I. Zucker, Doctor N. Nakashima

About the event

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources